COMPANY
Built in London. Designed for disciplined global execution.
CleverSkin Technologies Limited is a London-based medical technology company developing a point-of-use polyurethane wound-covering platform. The current company focus is not on making the broadest possible claim. It is on converting a defined product into current evidence, representative manufacture, lawful market entry and repeatable paid demand.
Management
Vadzim Tsitou · CEO & Founder
Full-time founder and executive lead. Responsible for company strategy, fundraising, commercialisation, international development and programme execution.
Dr John Butler · Medical Innovation Director
Fractional medical innovation leadership supporting clinical context, medical review and development of appropriate evidence and communication boundaries.
CleverSkin also works with specialist advisers across clinical and wound care, regulatory and quality, manufacturing and supply, capital and governance, market access and international localisation. Management remains accountable for decisions and controlled external claims.
What we are building now
- A current-product evidence package for CleverSkin24.
- Representative manufacturing and host-manufacturer readiness.
- A controlled UK / EU / US regulatory route.
- First-aid kit, OEM, distributor and institutional paid-pilot pathways.
- A wider platform roadmap that expands only when evidence and regulatory controls support it.